LA BELLA, Vincenzo
 Distribuzione geografica
Continente #
NA - Nord America 12.334
EU - Europa 6.334
AS - Asia 5.264
SA - Sud America 703
AF - Africa 175
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 7
Totale 24.843
Nazione #
US - Stati Uniti d'America 12.191
SG - Singapore 1.923
RU - Federazione Russa 1.573
IT - Italia 1.448
CN - Cina 1.298
HK - Hong Kong 579
FI - Finlandia 571
BR - Brasile 565
UA - Ucraina 544
DE - Germania 515
VN - Vietnam 514
GB - Regno Unito 365
PL - Polonia 342
IE - Irlanda 267
FR - Francia 243
JP - Giappone 214
SE - Svezia 141
IN - India 133
BD - Bangladesh 122
KR - Corea 121
CA - Canada 74
NL - Olanda 71
BE - Belgio 63
IQ - Iraq 58
AR - Argentina 52
RO - Romania 51
TR - Turchia 44
CI - Costa d'Avorio 42
MX - Messico 39
ES - Italia 35
ZA - Sudafrica 31
AT - Austria 30
PK - Pakistan 30
SA - Arabia Saudita 26
AU - Australia 25
PH - Filippine 24
UZ - Uzbekistan 24
MY - Malesia 23
EG - Egitto 20
ID - Indonesia 19
IR - Iran 19
MA - Marocco 18
CO - Colombia 17
VE - Venezuela 17
EC - Ecuador 15
TN - Tunisia 14
CH - Svizzera 13
NG - Nigeria 13
GR - Grecia 11
CL - Cile 10
JO - Giordania 10
TW - Taiwan 10
KE - Kenya 9
AE - Emirati Arabi Uniti 8
BG - Bulgaria 8
IL - Israele 8
PY - Paraguay 8
AZ - Azerbaigian 7
BO - Bolivia 7
DZ - Algeria 7
KZ - Kazakistan 7
OM - Oman 7
DO - Repubblica Dominicana 6
JM - Giamaica 6
KG - Kirghizistan 6
PE - Perù 6
SY - Repubblica araba siriana 6
DK - Danimarca 5
ET - Etiopia 5
NO - Norvegia 5
NP - Nepal 5
TH - Thailandia 5
AL - Albania 4
EU - Europa 4
HN - Honduras 4
HR - Croazia 4
LB - Libano 4
SN - Senegal 4
UY - Uruguay 4
BH - Bahrain 3
CR - Costa Rica 3
LT - Lituania 3
NI - Nicaragua 3
RS - Serbia 3
SD - Sudan 3
SI - Slovenia 3
TT - Trinidad e Tobago 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AO - Angola 2
BY - Bielorussia 2
GA - Gabon 2
GY - Guiana 2
HU - Ungheria 2
KH - Cambogia 2
LK - Sri Lanka 2
LY - Libia 2
MU - Mauritius 2
SK - Slovacchia (Repubblica Slovacca) 2
AM - Armenia 1
AW - Aruba 1
Totale 24.824
Città #
Ashburn 1.549
Singapore 1.296
Fairfield 1.264
Woodbridge 753
Chandler 726
San Jose 644
Houston 567
Wilmington 552
Hong Kong 545
Seattle 523
Ann Arbor 519
Cambridge 407
Jacksonville 299
Zgierz 295
Moscow 271
Dublin 257
Beijing 229
Dallas 221
Palermo 208
Medford 202
Tokyo 197
Council Bluffs 195
Frankfurt am Main 195
Santa Clara 184
Des Moines 173
Los Angeles 172
Ho Chi Minh City 165
Nanjing 153
New York 138
Princeton 137
Hanoi 135
Lauterbourg 132
Boardman 129
Milan 105
Altamura 104
The Dalles 97
Lawrence 92
Dearborn 90
San Diego 87
Tulsa 82
Chicago 73
Buffalo 69
Hefei 63
São Paulo 63
Helsinki 62
Brussels 56
Hebei 51
London 51
Nanchang 50
Jinan 46
Venice 44
Shenyang 43
Abidjan 42
Ludwigshafen am Rhein 39
Falls Church 37
Atlanta 36
Orem 36
Changsha 34
Rome 34
Ningbo 30
Da Nang 29
Norwalk 29
Tianjin 29
Verona 29
Guangzhou 27
Montreal 27
Phoenix 27
Warsaw 27
Columbus 26
Zhengzhou 26
Chennai 25
Seongnam 25
Denver 24
Washington 23
Hangzhou 22
Rio de Janeiro 22
Haiphong 21
Saint Petersburg 21
Stockholm 21
Turin 21
San Paolo di Civitate 20
Jiaxing 19
Nuremberg 19
Tashkent 19
Baghdad 18
Dhaka 18
Salt Lake City 18
Cardiff 17
Johannesburg 17
Mumbai 17
Piscataway 17
San Francisco 17
Secaucus 17
Boston 16
Bremen 16
Brooklyn 16
Lanzhou 16
Auburn Hills 15
Kumar 15
Munich 15
Totale 15.891
Nome #
INDIVIDUAL AND HEALTH-RELATED QUALITY OF LIFE ASSESSMENT IN AMYOTROPHIC LATERAL SCLEROSIS PATIENTS AND THEIR CAREGIVERS 453
A rapidly progressive motor neuron disease associated to a natural killer cells leukaemia 411
The MITOS system predicts long-term survival in amyotrophic lateral sclerosis 322
Cerebrospinal fluid tau protein is not a biological marker in amyotrophic lateral sclerosis. 322
A Human-Humanoid Interaction through the use of BCI for Locked-In ALS Patients using neuro-biological feedback fusion 304
INCIDENCE OF AMYOTROPHIC LATERAL SCLEROSIS IN SICILY: A POPULATION BASED STUDY. 302
Plasma cortisol level in amyotrophic lateral sclerosis 293
CLINICAL CHARACTERISTICS OF PATIENTS WITH FAMILIAL AMYOTROPHIC LATERAL SCLEROSIS CARRYING THE PATHOGENIC GGGGCC HEXANUCLEOTIDE REPEAT EXPANSION OF C9ORF72 286
FACTORS AFFECTING THE DIAGNOSTIC DELAY IN AMYOTROPHIC LATERAL SCLEROSIS 286
Reaching and grasping a glass of water by locked-In ALS patients through a BCI-controlled humanoid robot 275
A two-stage genome-wide association study of sporadic amyotrophic lateral sclerosis. 267
FUS MUTATIONS IN SPORADIC AMYOTROPHIC LATERAL SCLEROSIS: CLINICAL AND GENETIC ANALYSIS 256
Causes and place of death in Italian patients with amyotrophic lateral sclerosis 255
Ethical issues: invasive ventilation in amyotrophic lateral sclerosis 250
A CERVICAL MYELOPATHY WITH A HIRAYAMA DISEASE-LIKE PHENOTYPE 244
Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis 240
TELEPHONE FOLLOW-UP FOR PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS 236
Ataxin-1 and ataxin-2 intermediate-length PolyQ expansions in amyotrophic lateral sclerosis. 235
NONINVASIVE POSITIVE-PRESSURE VENTILATION IN ALS. Predictors of tolerance and survival 233
FATIGUE, SLEEP, AND NOCTURNAL COMPLAINTS IN PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS. 233
Elevated cerebrospinal fluid and plasma homocysteine levels in ALS. 227
REM sleep behavior disorder and periodic leg movements during sleep in ALS 225
Carcinoma of the tongue and bulbar-onset amyotrophic lateral sclerosis: unusual differential diagnosis. 224
Two Italian kindreds with familial amyotrophic lateral sclerosis due to FUS mutation 224
Erythropoietin in amyotrophic lateral sclerosis: a multicentre, randomised, double blind, placebo controlled, phase III study 223
Dysembryoplastic Neuroepithelial Tumor of the brainstem 220
DEVELOPMENT OF CHRONIC HYPOVENTILATION IN AMYOTROPHIC LATERAL SCLEROSIS PATIENTS 220
Binding of flunitrazepam to differentiating neurons cultured in a chemically defined, hormone-supplemented medium 219
ACUTE REVERSIBLE PARKINSONISM IN A DIABETIC-UREMIC PATIENT 219
ACUTE REVERSIBLE PARKINSONISM IN A DIABETIC UREMIC PATIENT 218
DJ-1 mutations and parkinsonism-dementia-amyotrophic lateral sclerosis complex 218
ALS-Related Mutant FUS Protein Is Mislocalized to Cytoplasm and Is Recruited into Stress Granules of Fibroblasts from Asymptomatic FUS P525L Mutation Carriers 215
TRACHEOSTOMY MECHANICAL VENTILATION IN PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS: CLINICAL FEATURES AND SURVIVAL ANALYSIS. 211
C9ORF72 HEXANUCLEOTIDE REPEAT EXPANSIONS IN THE ITALIAN SPORADIC ALS POPULATION. 208
MTHFR C677T allelic variant is not associated to plasma and cerebrospinal fluid homocysteine in Amyotrophic Lateral Sclerosis 204
ALS-linked FUS mutations confer loss and gain of function in the nucleus by promoting excessive formation of dysfunctional paraspeckles 202
The amyotrophic lateral sclerosis functional rating scale predicts survival time in amyotrophic lateral sclerosis patients on invasive mechanical ventilation. 200
Cerebral Venous Sinus Espansion in Post Puncture Headache 198
EXPRESSION OF VESICLE-ASSOCIATED MEMBRANE-PROTEIN-ASSOCIATED PROTEIN B CLEAVAGE PRODUCTS IN PERIPHERAL BLOOD LEUKOCYTES AND CEREBROSPINAL FLUID OF PATIENTS WITH SPORADIC AMYOTROPHIC LATERAL SCLEROSIS 197
A novel mutation (Thr116IIe) in the presenilin 1 gene in a patient with early-onset Alzheimer's disease 196
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene 194
Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for ALS. 193
Bilateral Iatrogenic Femoral Neuropathy 193
A NOVEL ANGIOGENIN GENE MUTATION IN A SPORADIC PATIENT WITH AMYOTROPHIC LATERAL SCLEROSIS FROM SOUTHERN ITALY 191
A PATIENT WITH FRONTOTEMPORAL DEMENTIA (FTD) AND MOTOR NEURON DISEASE (MND) CARRYING THE INTRON10+29 SUBSTITUTION IN MAPT 191
MARITAL STATUS IS A PROGNOSTIC FACTOR IN AMYOTROPHIC LATERAL SCLEROSIS 191
The b1 isoform of protocadherin-gamma (Pcdhg) interacts with the microtubule-destabilizing protein SCG10 189
CHCH10 mutations in an Italian cohort of familial and sporadic amyotrophic lateral sclerosis patients 189
Sleep-wake disturbances in patients with amyotrophic lateral sclerosis 187
Expression and developmental regulation of the cystine/glutamate exchanger (xc-) in the rat 185
A PATIENT WITH FRONTOTEMPORAL DEMENTIA (FTD) AND MOTOR NEURON DISEASE (MND) CARRYING THE INTRON10+29 SUBSTITUTION IN MAPT . 183
TELEPHONE FOLLOW-UP FOR PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS 181
Assessing Command-Following and Communication With Vibro-Tactile P300 Brain-Computer Interface Tools in Patients With Unresponsive Wakefulness Syndrome 181
SPORADIC PARKINSON DISEASE AND AMYOTROPHIC LATERAL SCLEROSIS COMPLEX (BRAIT-FAHN-SCHWARTZ DISEASE). 180
Post-Translational Modifications in the Survival Motor Neuron Protein 179
Levetiracetam in the Treatment of Creutzfeldt-Jacob Disease. 178
TOXICITY OF B-N-OXALYLAMINO-L-ALANINE ANDB-N-METHYLAMINO-L-ALANINE IN NIH3T3 CELLS IS MEDIATED BY INHIBITIONOF THE XC¯ ANTIPORTER 175
Percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis 174
Repeated courses of granulocyte colony-stimulating factor in amyotrophic lateral sclerosis: clinical and biological results from a prospective multicenter study 173
Architecture of cell differentiation, stress-mediated protein expression and transport in iPSC-derived Motor Neurons bearing a pG376D TDP-43 mutation 172
LA DISFUNZIONE RESPIRATORIA NELLA SCLEROSI LATERALE AMIOTROFICA 171
CSF homocysteine levels in Amyotrophic Lateral Sclerosis 171
THORACIC SYRINGOMYELIA IN A PATIENT WITH AMYOTROPHIC LATERAL SCLEROSIS 171
Biomarkers Related to Synaptic Dysfunction to Discriminate Alzheimer's Disease from Other Neurological Disorders 169
High frequency of motoneuron dysfunction in FTD: a clinical and electrophysiological study 169
CSF neurofilament proteins as diagnostic and prognostic biomarkers for amyotrophic lateral sclerosis 168
FURTHER EVIDENCE THAT D90A-SOD1 MUTATION IS RECESSIVELY INHERITED IN ALS PATIENTS IN ITALY 167
UNILATERAL LARYNGEAL AND HYPOGLOSSAL PARALYSIS (TAPIA'S SYNDROME) IN A PATIENT WITH AN INFLAMMATORY PSEUDOTUMOR OF THE NECK. 166
ATNX2 is not a regulatory gene in Italian amyotrophic lateral sclerosis patients with C9ORF72 GGGGCC expansion 166
Could mitochondrial haplogroups play a role in sporadic amyotrophic lateral sclerosis? 165
LONG-LASTING CRANIAL NERVE III PALSY AS A PRESENTING FEATURE OF CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY 164
LEVITIRACETAM IN THE TREATMENT OF CREUTZFIELDT-JACOB DISEASE 163
NEUROPHYSIOLOGIC AND CLINICAL SIGNS OF MOTONEURONAL DEGENERATION IN FRONTOTEMPORAL DEMENTIA 162
G-CSF (filgrastim) treatment for amyotrophic lateral sclerosis: protocol for a phase II randomised, double-blind, placebo-controlled, parallel group, multicentre clinical study (STEMALS-II trial) 162
Prognostic Role of CSF β-amyloid 1-42/1-40 Ratio in Patients Affected by Amyotrophic Lateral Sclerosis 162
A PHASE I-II MULTICENTRE STUDY ON G-CSF IN AMYOTROPHIC LATERAL SCLEROSIS (STEMALS) 161
URIC ACID LEVELS IN SERUM AND CSF OF ALS PATIENTS 161
CSF HOMOCYSTEINE LEVELS IN AMYOTROPHC LATERAL SCLEROSIS 160
ATXN2 trinucleotide repeat length correlates with risk of ALS 160
Performance Differences Using a Vibro-Tactile P300 BCI in LIS-Patients Diagnosed With Stroke and ALS 160
Early and rapidly progressing respiratory failure in a patient with amyotrophic lateral sclerosis: when FVC% is misleading 159
DIABETIC THORACIC POLYRADICULOPATHY: A CASE WITH CLINICAL IMPROVEMENT FROM INTRAVENOUS IMMUNOGLOBULIN. 156
Response to the letter to the Editor: Comments on marital status is a prognostic factor in amyotrophic lateral sclerosis. Safiri S et al 156
A PHASE I-II MULTICENTRE STUDY ON G-CSF IN AMYOTROPHIC LATERAL SCLEROSIS 155
Effects of a Vibro-Tactile P300 Based Brain-Computer Interface on the Coma Recovery Scale-Revised in Patients With Disorders of Consciousness 155
CONSISTENT BONE MARROW-DERIVED CELL MOBILIZATION FOLLOWING REPEATED SHORT COURSES OF GRANULOCYTE-COLONY-STIMULATING FACTOR IN PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS: RESULTS FROM A MULTICENTER PROSPECTIVE TRIAL. 154
MTHFR C677T allelic variant is not associated to plasma and cerebrospinal fluid homocysteine in amyotrophic lateral sclerosis 153
E163L HOMOZYGOUS DJ-1 MUTATION IN A FAMILY FROM SOUTHERN ITALY WITH AMIOTROPHIC LATERAL SCLEROSIS-PARKINSONISM-DEMENTIA COMPLEX. 149
SPORADIC ALS IS NOT ASSOCIATED WITH VAPB GENE MUTATIONS IN SOUTHERN ITALY 149
Mutations in ATP13A2 (PARK9) are associated with an amyotrophic lateral sclerosis-like phenotype, implicating this locus in further phenotypic expansion 149
Evaluation of Alpha-Synuclein Cerebrospinal Fluid Levels in Several Neurological Disorders 148
Allele-specific silencing as therapy for familial amyotrophic lateral sclerosis caused by the p.G376D TARDBP mutation 146
RESTLESS LEGS SYNDROME IN PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS: A CASE-CONTROL STUDY. 146
Role of the immune system in amyotrophic lateral sclerosis. Analysis of the natural killer cells and other circulating lymphocytes in a cohort of ALS patients 141
ESPRESSIONE DELL’ANTIPORTER CISTINA/GLUTAMMATO XC- NEL SISTEMA NERVOSO DI RATTO 141
A novel S379A TARDBP mutation associated to late-onset sporadic ALS 141
SISTEMA NEUROVEGETATIVO; PATOLOGIA E NOTE DI TERAPIA 140
Tumors preceding ALS onset and ALS: results from a case-control study. 140
EXPRESSION OF THE CYSTINE/GLUTAMATE EXCHANGER IN THE RAT BRAIN 139
Pulmonary function deterioration and chronic hypoventilation in Amyotrophic Lateral Sclerosis 139
Totale 19.904
Categoria #
all - tutte 87.981
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 87.981


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021199 0 0 0 0 0 0 0 0 0 0 0 199
2021/20221.694 77 402 38 63 69 99 96 81 190 205 109 265
2022/20232.272 232 377 53 236 236 379 161 147 235 82 82 52
2023/20241.276 49 135 121 139 148 230 116 55 25 58 23 177
2024/20252.719 79 191 191 249 129 125 152 161 170 338 374 560
2025/20269.102 647 251 524 606 819 1.299 1.261 960 898 1.425 314 98
Totale 25.335